What is jardiance used for
Pro Research Analysisby 
Searched over 200M research papers
Uses of Jardiance (Empagliflozin)
Treatment of Type 2 Diabetes
Glycemic Control in Adults and Children
Jardiance, known generically as empagliflozin, is primarily used to improve glycemic control in individuals with type 2 diabetes. It functions as a sodium-glucose cotransporter 2 (SGLT2) inhibitor, which helps to lower blood sugar levels by preventing glucose reabsorption in the kidneys. Initially approved for adult use, Jardiance has also been approved for children aged 10 years and older, either alone or in combination with metformin.
Cardiovascular Benefits
Reduction of Cardiovascular Death Risk
In addition to its role in managing blood sugar levels, Jardiance has been approved to reduce the risk of cardiovascular death in patients with type 2 diabetes who have established cardiovascular disease. This makes it a valuable option for diabetic patients who are at a higher risk of heart-related complications.
Safety Considerations
Warnings and Precautions
While Jardiance offers significant benefits, it also comes with important safety considerations. The use of empagliflozin has been associated with an increased risk of ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones. Additionally, there is a risk of acute kidney injury and impaired renal function, which necessitates careful monitoring of kidney health during treatment.
Conclusion
Jardiance (empagliflozin) is a versatile medication used primarily for improving glycemic control in type 2 diabetes patients, including children aged 10 and above. It also offers cardiovascular benefits by reducing the risk of cardiovascular death in patients with established heart disease. However, users must be aware of potential risks such as ketoacidosis and kidney injury, and should be monitored accordingly.
Sources and full results
Most relevant research papers on this topic